STERIS plc $STE Holdings Decreased by Snyder Capital Management L P

Snyder Capital Management L P reduced its holdings in STERIS plc (NYSE:STEFree Report) by 1.8% in the 3rd quarter, Holdings Channel reports. The fund owned 148,368 shares of the medical equipment provider’s stock after selling 2,667 shares during the period. Snyder Capital Management L P’s holdings in STERIS were worth $36,712,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Steigerwald Gordon & Koch Inc. purchased a new position in STERIS during the 3rd quarter valued at about $25,000. Cloud Capital Management LLC acquired a new stake in shares of STERIS during the third quarter worth approximately $29,000. Spurstone Advisory Services LLC purchased a new position in STERIS during the second quarter valued at approximately $29,000. Geneos Wealth Management Inc. increased its stake in STERIS by 416.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares during the period. Finally, TruNorth Capital Management LLC acquired a new position in STERIS in the 3rd quarter valued at approximately $37,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on STE. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $275.20.

Read Our Latest Analysis on STERIS

STERIS Stock Performance

STE stock opened at $243.37 on Thursday. The firm has a 50 day moving average of $255.21 and a two-hundred day moving average of $251.70. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The company has a market capitalization of $23.87 billion, a price-to-earnings ratio of 33.94 and a beta of 1.05. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26.

STERIS (NYSE:STEGet Free Report) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. As a group, equities analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be paid a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Tuesday, February 17th. STERIS’s dividend payout ratio is 35.15%.

STERIS Profile

(Free Report)

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

See Also

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.